FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Resnik

Research Profile

Concepts & Ideas

Geographic Areas

United States

Procedures

Living Beings

Physiology

Decision Making

Organizations

Federal Government

Activities & Behaviors

Co-author Network

Publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Resnik (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: David B Resnik; Zubin Master
Policies and initiatives aimed at addressing research misconduct in high-income countries.
PLoS medicine 2013;10(3):e1001406.
2013: David B Resnik
Plagiarism among collaborators.
Accountability in research 2013;20(1):1-4.
2013: David B Resnik; Gregg E Dinse
Scientific retractions and corrections related to misconduct findings.
Journal of medical ethics 2013;39(1):46-50.
2012: David B Resnik; Elizabeth Ness
Participants' responsibilities in clinical research.
Journal of medical ethics 2012;38(12):746-50.
2012: David B Resnik; Gregg E Dinse
Do U.S. research institutions meet or exceed federal mandates for instruction in responsible conduct of research? A national survey.
Academic medicine : journal of the Association of American Medical Colleges 2012;87(9):1237-42.
2012: David B Resnik; Gwen Babson; Gregg E Dinse
Minor changes to previously approved research: a study of IRB policies.
IRB 2012;34(4):9-14.
2012: David B Resnik
Ethical virtues in scientific research.
Accountability in research 2012;19(6):329-43.
2012: David B Resnik
Editorial: plagiarism: words and ideas.
Accountability in research 2012;19(5):269-72.
2012: David B Resnik; C Neal Stewart
Misconduct versus honest error and scientific disagreement.
Accountability in research 2012;19(1):56-63.
2011: David B Resnik; Zubin Master
Criteria for authorship in bioethics.
The American journal of bioethics : AJOB 2011;11(10):17-21.
2011: David B Resnik
Scientific research and the public trust.
Science and engineering ethics 2011;17(3):399-409.
2011: David B Resnik; Zubin Master
Authorship policies of bioethics journals.
Journal of medical ethics 2011;37(7):424-8.
2011: David B Resnik
Reopening old divisions.
The American journal of bioethics : AJOB 2011;11(6):19-21.
2011: David B Resnik; Greg Koski
A national registry for healthy volunteers in phase 1 clinical trials.
JAMA : the journal of the American Medical Association 2011;305(12):1236-7.
2011: David B Resnik; Dionne D Barner; Gregg E Dinse
Dual-use review policies of biomedical research journals.
Biosecurity and bioterrorism : biodefense strategy, practice, and science 2011;9(1):49-54.
2011: David B Resnik; Adil E Shamoo
The singapore statement on research integrity.
Accountability in research 2011;18(2):71-5.
2010: David B Resnik
Urban sprawl, smart growth, and deliberative democracy.
American journal of public health 2010;100(10):1852-6.
2010: David B Resnik; Frank Miller
The ethics of sham surgery on research subjects with cognitive impairments that affect decision-making capacity.
Contemporary clinical trials 2010;31(5):407-10.
2010: David B Resnik; Caitlin E Kennedy
Balancing scientific and community interests in community-based participatory research.
Accountability in research 2010;17(4):198-210.
2010: David B Resnik
Practical and political problems with a global research tax.
The American journal of bioethics : AJOB 2010;10(6):44-5.
2010: David B Resnik
Public trust as a policy goal for research with human subjects.
The American journal of bioethics : AJOB 2010;10(6):15-7.
2010: David B Resnik; Daniel Patrone; Shyamal Peddada
Research misconduct policies of social science journals and impact factor.
Accountability in research 2010;17(2):79-84.
2010: David B Resnik
Genomic research data: open vs. restricted access.
IRB 2010;32(1):1-6.
2010: David B Resnik; Daniel Patrone; Shyamal Peddada
Evaluating the quality of information about alternatives to research participation in oncology consent forms.
Contemporary clinical trials 2010;31(1):18-21.
2009: David B Resnik
Re-consenting human subjects: ethical, legal and practical issues.
Journal of medical ethics 2009;35(11):656-7.
2009: David B Resnik
Perspective: Disclosing hidden sources of funding.
Academic medicine : journal of the Association of American Medical Colleges 2009;84(9):1226-8.
2009: David B Resnik
Human health and the environment: in harmony or in conflict?
Health care analysis : HCA : journal of health philosophy and policy 2009;17(3):261-76.
2009: David B Resnik
Environmental health research and the observer's dilemma.
Environmental health perspectives 2009;117(8):1191-4.
2009: David B Resnik
International standards for research integrity: An idea whose time has come?
Accountability in research 2009;16(4):218-28.
2009: David B Resnik
Parent-investigators: a dilemma.
JAMA : the journal of the American Medical Association 2009;301(20):2159-61.
2009: David B Resnik
Do informed consent documents matter?
Contemporary clinical trials 2009;30(2):114-5.
2009: David B Resnik
Direct-to-consumer genomics, social networking, and confidentiality.
The American journal of bioethics : AJOB 2009;9(6-7):45-6.
2009: David B Resnik
The clinical investigator-subject relationship: a contextual approach.
Philosophy, ethics, and humanities in medicine : PEHM 2009;4():16.
2009: David B Resnik; Shyamal Peddada; Winnon Brunson
Research misconduct policies of scientific journals.
Accountability in research 2009;16(5):254-67.
2008: David B Resnik; Shyamal Peddada; Jason Altilio; Nancy Wang; Jerry Menikoff
Oncology consent forms: failure to disclose off-site treatment availability.
IRB 2008;30(6):7-11.
2008: David B Resnik
Closing loopholes in the federal research regulations: some practical problems.
The American journal of bioethics : AJOB 2008;8(11):6-8.
2008: David B Resnik; Christina Gutierrez-Ford; Shyamal Peddada
Perceptions of ethical problems with scientific journal peer review: an exploratory study.
Science and engineering ethics 2008;14(3):305-10.
2008: David B Resnik
Hidden sources of private industry funding.
The American journal of bioethics : AJOB 2008;8(8):60-1.
2008: David B Resnik
Research ethics consultation at the National Institute of Environmental Health Sciences.
The American journal of bioethics : AJOB 2008;8(3):40-2; discussion W4-6.
2008: David B Resnik
Randomized controlled trials in environmental health research: ethical issues.
Journal of environmental health 2008;70(6):28-30.
2007: David B Resnik
Are the new EPA regulations concerning intentional exposure studies involving children overprotective?
IRB 2007;29(5):15-9.
2007: David B Resnik
Embryonic stem cell patents and human dignity.
Health care analysis : HCA : journal of health philosophy and policy 2007;15(3):211-22.
2007: David B Resnik
Responsibility for health: personal, social, and environmental.
Journal of medical ethics 2007;33(8):444-5.
2007: David B Resnik; Sally S Tinkle
Ethical issues in clinical trials involving nanomedicine.
Contemporary clinical trials 2007;28(4):433-41.
2007: David B Resnik; Sally S Tinkle
Ethics in nanomedicine.
Nanomedicine (London, England) 2007;2(3):345-50.
2007: David B Resnik; Gerard Roman
Health, justice, and the environment.
Bioethics 2007;21(4):230-41.
2007: David B Resnik
Neuroethics, national security and secrecy.
The American journal of bioethics : AJOB 2007;7(5):14-5.
2007: Kenneth Wilson; Alan Schreier; Angel Griffin; David B Resnik
Research records and the resolution of misconduct allegations at research universities.
Accountability in research 2007;14(1):57-71.
2007: David B Resnik
Intentional exposure studies of environmental agents on human subjects: assessing benefits and risks.
Accountability in research 2007;14(1):35-55.
2007: David B Resnik
The new EPA regulations for protecting human subjects: haste makes waste.
The Hastings Center report 2007;37(1):17-21.
2006: David B Resnik
Compensation for research-related injuries. Ethical and legal issues.
The Journal of legal medicine 2006;27(3):263-87.
2006: David B Resnik; Richard R Sharp
Protecting third parties in human subjects research.
IRB 2006;28(4):1-7.
2006: Adil E Shamoo; David B Resnik
Strategies to minimize risks and exploitation in phase one trials on healthy subjects.
The American journal of bioethics : AJOB 2006;6(3):W1-13.
2006: David B Resnik; Daniel B Vorhaus
Genetic modification and genetic determinism.
Philosophy, ethics, and humanities in medicine : PEHM 2006;1(1):E9.
2006: David B Resnik
The ethics and regulation of research with human subjects, Carl Coleman, Jerry Menikoff, Jesse Goldner, and Nancy Dubler, eds., (LexisNexis) 2005.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 2006;34(2):465-6.
2006: David B Resnik; Adil E Shamoo; Sheldon Krimsky
Fraudulent human embryonic stem cell research in South Korea: lessons learned.
Accountability in research 2006;13(1):101-9.
2006: Alan A Schreier; Kenneth Wilson; David B Resnik
Academic research record-keeping: best practices for individuals, group leaders, and institutions.
Academic medicine : journal of the Association of American Medical Colleges 2006;81(1):42-7.
2005: David B Resnik
Using electronic discussion boards to teach responsible conduct of research.
Science and engineering ethics 2005;11(4):617-30.
2005: David B Resnik; Christopher Portier
Pesticide testing on human subjects: weighing benefits and risks.
Environmental health perspectives 2005;113(7):813-7.
2005: David B Resnik; Darryl C Zeldin; Richard R Sharp
Research on environmental health interventions: ethical problems and solutions.
Accountability in research 2005;12(2):69-101.
2005: David B Resnik
The patient's duty to adhere to prescribed treatment: an ethical analysis.
The Journal of medicine and philosophy 2005;30(2):167-88.
2005: David B Resnik
Conflicts of interest at the NIH: no easy solution.
The Hastings Center report 2005;35(1):18-20.
2005: David B Resnik
Eliminating the daily life risks standard from the definition of minimal risk.
Journal of medical ethics 2005;31(1):35-8.
2004: David B Resnik
The precautionary principle and medical decision making.
The Journal of medicine and philosophy 2004;29(3):281-99.
2004: David B Resnik
Fair drug prices and the patent system.
Health care analysis : HCA : journal of health philosophy and policy 2004;12(2):91-115.
2004: David B Resnik
Liability for institutional review boards: from regulation to litigation.
The Journal of legal medicine 2004;25(2):131-84.
2004: David B Resnik
The distribution of biomedical research resources and international justice.
Developing world bioethics 2004;4(1):42-57.
2004: David B Resnik
Terrorism and intellectual property rights.
The virtual mentor : VM 2004;6(5):.
2004: David B Resnik
Research subjects in developing nations and vulnerability.
The American journal of bioethics : AJOB 2004;4(3):63-4; discussion W32.
2004: David B Resnik
Coercion and the SATURN study.
The American journal of bioethics : AJOB 2004;4(1):38-40.
2003: David B Resnik
Genetic testing and primary care: a new ethic for a new setting.
New genetics and society 2003;22(3):245-56.
2003: David B Resnik
Are DNA patents bad for medicine?
Health policy (Amsterdam, Netherlands) 2003;65(2):181-97.
2003: David B Resnik
Strengthening the United States' database protection laws: balancing public access and private control.
Science and engineering ethics 2003;9(3):301-18.
2003: David B Resnik
From Baltimore to Bell Labs: reflections on two decades of debate about scientific misconduct.
Accountability in research 2003;10(2):123-35.
2003: David B Resnik
Patents on human-animal chimeras and threats to human dignity.
The American journal of bioethics : AJOB 2003;3(3):35-6.
2003: David B Resnik
Exploitation in biomedical research.
Theoretical medicine and bioethics 2003;24(3):233-59.
2002: Ronald Perkin; David B Resnik
Response to Kuhse.
Journal of medical ethics 2002;28(4):273-4; discussion 274.
2002: Ronald Perkin; David B Resnik
The agony of agonal respiration: is the last gasp necessary?
Journal of medical ethics 2002;28(3):164-9.
2002: David B Resnik; Kenneth A DeVille
Response to commentaries : Resnik, D. B. and K. A. DeVille. 2002. "Bioterrorism and patient rights: 'compulsory licensure' and the case of Cipro." The American Journal of Bioethics 2(3): 29-39.
The American journal of bioethics : AJOB 2002;2(4):W1.
2002: David B Resnik; Adil E Shamoo
Conflict of interest and the university.
Accountability in research 2002;9(1):45-64.
2002: David B Resnik; Kenneth A DeVille
Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro.
The American journal of bioethics : AJOB 2002;2(3):29-39.
2002: David B Resnik
The commercialization of human stem cells: ethical and policy issues.
Health care analysis : HCA : journal of health philosophy and policy 2002;10(2):127-54.
2002: David B Resnik
Exploitation and the ethics of clinical trials.
The American journal of bioethics : AJOB 2002;2(2):28-30.
2001: David B Resnik
Setting biomedical research priorities: justice, science, and public participation.
Kennedy Institute of Ethics journal 2001;11(2):181-204.
2001: David B Resnik
Developing drugs for the developing world: an economic, legal, moral, and political dilemma.
Developing world bioethics 2001;1(1):11-32.
2001: David B Resnik
Regulating the market for human eggs.
Bioethics 2001;15(1):1-25.
2001: David B Resnik
Ethical dilemmas in communicating medical information to the public.
Health policy (Amsterdam, Netherlands) 2001;55(2):129-49.
2001: David B Resnik
The concept of disability in bioethics: theoretical and clinical issues.
The American journal of bioethics : AJOB 2001;1(3):46-8.
2001: David B Resnik
Difficulties with regulating sex selection.
The American journal of bioethics : AJOB 2001;1(1):21-3.
2001: David B Resnik
DNA patents and human dignity.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 2001;29(2):152-65.
2001: David B Resnik
Patient access to medical information in the computer age: ethical concerns and issues.
Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees 2001;10(2):147-54; discussion 154-6.
2001: David B Resnik
DNA patents and scientific discovery and innovation: assessing benefits and risks.
Science and engineering ethics 2001;7(1):29-62.
2000: David B Resnik; P L Ranelli; S P Resnik
The conflict between ethics and business in community pharmacy: what about patient counseling?
Journal of business ethics : JBE 2000;28(2):179-86.
2000: David B Resnik
Of maize and men: reproductive control and the threat to genetic diversity.
The Journal of medicine and philosophy 2000;25(4):451-67.
2000: David B Resnik
The moral significance of the therapy-enhancement distinction in human genetics.
Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees 2000;9(3):365-77.
1999: David B Resnik
The hazards of studying human genetic variation.
Politics and the life sciences : the journal of the Association for Politics and the Life Sciences 1999;18(2):338-40.
1999: David B Resnik
Sex biases in subject selection: a survey of articles published in American medical journals.
Theoretical medicine and bioethics 1999;20(3):245-60.
1999: David B Resnik
Privatized biomedical research, public fears, and the hazards of government regulation: lessons from stem cell research.
Health care analysis : HCA : journal of health philosophy and policy 1999;7(3):273-87.
1998: David B Resnik
The commodification of human reproductive materials.
Journal of medical ethics 1998;24(6):388-93.